MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2017 International Congress

    Predictor of progressive mild cognitive impairment in patients with Parkinson’s disease.

    Y. Tajiri, K. Wada-Isoe, M. Hamada, M. Sawada, K. Nakashima (Yonago, Japan)

    Objective: To clarify clinical features of patients with progressive mild cognitive impairment patients (MCI) in Parkinson’s disease (PD-MCI). Background: Non-demented PD subjects have MCI and…
  • 2017 International Congress

    Subcortical involvement in body and mental action processing: an electrophysiological registration study

    M. De Letter, P. Santens, D. Van Roost, G. Strobbe, P. Van Mierlo, A. Aerts, A. Bruggeman, K. De Keyser (Ghent, Belgium)

    Objective: The current research project focusses on the electrophysiological registration of semantics (body versus mental action verbs) within the thalamus, subthalamic nucleus (STN) and the…
  • 2017 International Congress

    Motor resonance in Parkinson’s disease: Effects of observed actions on behaviour

    E. Poliakoff, J. Bek, S. Vogt, T. Crawford, E. Gowen (Manchester, United Kingdom)

    Objective: To investigate whether people with Parkinson’s disease (PD) exhibit motor resonance from observed human actions. Background: Seeing another person move can influence one’s own…
  • 2017 International Congress

    Consideration of the relationship between severity of Parkinson’s disease and cognitive function, depression, quality of life

    M. Saruwatari, M. Sagawa, A. Kumon, K. Hasegawa (Sagamihara, Japan)

    Objective: In this study, we aimed to clarify the relationship between PD severity and cognitive function, depression and quality of life. Background: We are continuing…
  • 2017 International Congress

    Interval from onset of Parkinson disease to onset of motor and non-motor complications in Leucine-rich repeat kinase 2 (LRRK2) G2019S positive versus matched PD controls

    S. Gunzler, D. Riley, A. Wilson-Delfosse, S. Chen, J. Mieyal, C. Tatsuoka (Cleveland, OH, USA)

    Objective: To compare the latency between onset of Parkinson disease (PD) symptoms and onset of motor and non-motor complications of PD, between G2019S LRRK2 mutation…
  • 2017 International Congress

    Genetic analysis of RAB39B mutations in early-onset and familial Parkinson’s Disease in a Taiwanese population.

    C.-H. Lin, H.-H. Lin, R.-M. Wu, H.-I. Lin (Taipei, Taiwan)

    Objective: To examine the genetic contribution of RAB39B to early-onset and familial PD in a Taiwanese population. Background: Loss of function mutations in RAB39B were…
  • 2017 International Congress

    Genetic and pharmacological rescue of DJ-1 loss-of-function caused by a c.192G>C mutation in PARK7

    I. Boussaad, C. Obermaier, Z. Hanss, N. Weisschuh, B. Schmid, S. Hoffmann, L. Burbulla, C. Klein, S. Duga, D. Krainc, T.G. Gasser, B. Wissinger, R. Krüger (Esch-sur-Alzette, Luxembourg)

    Objective: In this study we investigate the cellular mechanism underlying the Parkinson’s disease (PD)-associated mutation c.192G>C in PARK7 and present a compound treatment that rescues…
  • 2017 International Congress

    First Reported Case of Parkinsonism in a Patient with Argininosuccinate Lyase Deficiency

    K. Woodward, D. Bhatti, E. Rush (Omaha, NE, USA)

    Objective: The purpose of this case report is to detail the phenotype of parkinsonism encountered in a patient with Argininosuccinate Lyase Deficiency (ASLD) that has…
  • 2017 International Congress

    Absence of depression in de novo Parkinson’s disease: a benign motor phenotype?

    H.S. YOO, Y. Lee, J.J. Lee, S.J. Chung, P.H. Lee, Y.H. Sohn (Seoul, Republic of Korea)

    Objective: This study aimed to assess the impact of early depression on motor deficits relative to the level of striatal dopaminergic depletion in patients with…
  • 2017 International Congress

    Serum uric acid levels and freezing of gait in Parkinson’s disease

    R. Ou, B. Cao, Q. Wei, Y. Hou, Y. Xu, W. Song, B. Zhao (Chengdu, China)

    Objective: To investigate the relationship between serum Uric acid (UA) levels and freezing of gait (FOG) in Parkinson’s disease (PD). Background: UA is a natural…
  • « Previous Page
  • 1
  • …
  • 53
  • 54
  • 55
  • 56
  • 57
  • …
  • 155
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • #23285 (not found)
  • The hardest symptoms that bother patients with Parkinson's disease
  • Life expectancy with and without Parkinson’s disease in the general population
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley